ROUNDTABLE: Biosimilar Development Concerns – Collaboration, Capacity, and CMOs

This podcast features:
Chairperson:
Patti Seymour, Senior Consultant, BioProcess Technology Consultants

Speaker/Panelists:
Thomas J. Vanden Boom, Vice President, Global Biologics Research, Hospira
Dr. Uwe Buecheler, Senior Vice President, Biopharmaceutical Operations, Boehringer Ingelheim
Michiel E. Ultee, PhD, Chief Scientific Officer, Laureate Biopharma
Richard Brudnick, Vice President, BD/M&A, BiogenIdec

 


 

This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting the development and manufacture of biotherapeutics.

The 2013 BioProcess Theater consisted of five main presentation tracks: Biosimilars, Single-Use Processing, Cell Therapy, Antibody/Non-Antibody Manufacturing, and Vaccine Manufacturing.

If you would like more information on these presentations, please email us: info@bioprocessintl.com

Leave a Reply